Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLong-Term Debt Issuances
Ratios

Greater Cannabis Company (GCAN) Cost of Revenue (2017 - 2022)

Greater Cannabis Company's Cost of Revenue history spans 6 years, with the latest figure at $11017.0 for Q4 2022.

  • For Q4 2022, Cost of Revenue changed N/A year-over-year to $11017.0; the TTM value through Dec 2022 reached $52035.0, down 47.05%, while the annual FY2025 figure was $60788.0, 94.36% up from the prior year.
  • Cost of Revenue reached $11017.0 in Q4 2022 per GCAN's latest filing, down from $18054.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $107077.0 in Q2 2019 to a low of -$162088.0 in Q4 2019.
  • Average Cost of Revenue over 5 years is $14968.1, with a median of $18364.5 recorded in 2020.
  • The largest YoY upside for Cost of Revenue was 71763.76% in 2019 against a maximum downside of 903.69% in 2019.
  • A 5-year view of Cost of Revenue shows it stood at $20168.0 in 2018, then crashed by 903.69% to -$162088.0 in 2019, then surged by 111.52% to $18675.0 in 2020, then surged by 189.63% to $54088.0 in 2021, then tumbled by 79.63% to $11017.0 in 2022.
  • Per Business Quant, the three most recent readings for GCAN's Cost of Revenue are $11017.0 (Q4 2022), $18054.0 (Q3 2022), and $11784.0 (Q2 2022).